Issuer Jurisdiction: Switzerland

Use of Proceeds: Expansion financing

Early Exit / Redemption Option: Callable after year 3 at issuer option

ISIN: Assigned

Capital Return Mechanism: At maturity

Accepted Investment Currencies: CHF, EUR

The underlying issuer is active in Swiss MedTech Equipment Bond, a private-investor opportunity in the medical technology sector. The issuer or investment vehicle is established in Switzerland and the accepted investment currency is CHF. The instrument type is Bond, the total offering size is 18,000,000 CHF, and the minimum subscription amount is 500,000 CHF. The return profile is stated as Fixed 8.6% p.a. and the investment horizon is 6 years. The opportunity is intended for investors who require a clearly defined instrument, an assigned ISIN, and a standardised private-investor ticket size rather than a bespoke bilateral negotiation.

The economic basis of the opportunity is the issuer's existing activity in Switzerland, Germany. Current-year revenue is 39,000,000 CHF and current-year EBITDA is 7,600,000 CHF, compared with revenue of 35,200,000 CHF two years ago and 37,400,000 CHF one year ago. EBITDA for the same earlier periods is 6,200,000 CHF and 7,000,000 CHF. This gives the opportunity a visible operating profile: revenue has increased gradually, EBITDA has remained positive, and the current EBITDA margin is 19.5%. The balance sheet shows total assets of 69,000,000 CHF, equity of 30,360,000 CHF, long-term liabilities of 20,700,000 CHF and short-term liabilities of 17,940,000 CHF. The resulting equity ratio is 44.0%, while net debt to EBITDA is presented as 2.1x.

Use of proceeds is limited to the purpose stated in the dataset: Expansion financing. No additional categories such as capex, construction budget or working-capital breakdown are introduced outside the available fields. Revenue generation is described as follows: Sale and servicing of specialised medical technology equipment. This is important because the investment should be assessed on the basis of the information explicitly included in the table, not on assumed project-level data. The execution logic is therefore simple: the issuer continues its existing business activity, applies the capital to the stated financing purpose, and services the instrument through its operating cash flow, portfolio income, exit process or redemption mechanism according to the instrument type.

For this bond, capital return is expected at maturity and the distribution mechanism is annual coupon. The bond maturity is 6 years, which is consistent with the intended private-investor profile: most bond opportunities in the dataset fall around four to five years, with only a limited number extending toward six years. The security structure is stated as Secured by equipment. Where the bond is unsecured, the investor relies primarily on the issuer's operating scale, EBITDA generation, leverage level, equity base and repayment capacity; where security is stated, the collateral value and coverage ratio are disclosed in the specific collateral fields.

Investor protection and risk should be read directly from the structured fields. Collateral is recorded as: 24,300,000 CHF; collateral coverage is recorded as: 135.0%; description: Collateral over selected receivables/equipment with estimated 135% coverage.. The main risks are normal business, market, liquidity and execution risks associated with the issuer's sector and instrument type. Currency risk is also relevant for investors whose base currency differs from CHF. The jurisdiction and currency are intentionally aligned: Switzerland is used together with CHF so that the commercial presentation does not mix an issuer profile with an unrelated investment currency. This makes the entry internally coherent for publication on a private-investor platform.

The company or vehicle was established in 2014 and reports 120 full-time employees where applicable. Its core activity is described as Medical technology equipment and servicing. The brief history field states: Company developed a specialist equipment platform with recurring service revenues.. Ownership is recorded as Founders 64%, private investors 36%, and existing financing is recorded as Bank loan. These data points are kept consistent with the financial figures and do not introduce additional assumptions. 

Company / Project Description:

Swiss MedTech Equipment Bond operating in medical technology.

Revenue Generation Model:

Year Established: 2014

Number of Employees: 120

Key Markets: Switzerland, Germany

Core Business Activity:

Medical technology equipment and servicing

Brief History:

Reason for Capital Raising:

Company Stage:

Ownership Structure:

Existing Financing: Bank loan